Add Yahoo as a preferred source to see more of our stories on Google. Brooke was only three years old when she first learned about desmoid tumors. “My mother had six or seven,” she recalls. Brooke’s ...

Nirogacestat (Ogsiveo; Springworks Therapeutics) is a therapy used to treat desmoid tumors, rare but aggressive growths that ...

Panelists discuss the questions below in this video. What is the epidemiology and prognosis of desmoid tumor? Where on the body are desmoid tumors usually found? Can you please describe the ...

Registrational trial met primary endpoint, with varegacestat significantly improving progression-free survival vs. placebo (hazard ratio = 0.16, p<0.0001) Trial also met all key secondary endpoints, ...

Desmoid fibromatosis (DF) is a locally aggressive tumor with low mortality but significant morbidity. There is a lack of standard of care, and existing therapies are associated with significant ...

In their real-world study, Bajpai et al 7 expand our knowledge on the activity and safety of a combination presented as a novel metronomic regimen of vinblastine, methotrexate, and tamoxifen. They ...

SpringWorks Therapeutics announced that the European Medicine Agency’s Committee for Medicinal Products for Human Use has recommended the approval of nirogacestat, an oral gamma secretase inhibitor, ...

Brooke was only three years old when she first learned about desmoid tumors. “My mother had six or seven,” she recalls. Brooke’s mother also had 28 surgeries related to her desmoid tumors and multiple ...